Atossa Therapeutics, Inc.
Pharmaceutical company · Seattle, Washington, United States · Nasdaq: ATOS
Atossa Therapeutics, Inc. is a pharmaceutical company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2009. Its shares trade on Nasdaq under the ticker ATOS. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2013.
Atossa Therapeutics at a glance
What does Atossa Therapeutics do?
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $1 million sold (2013).
Frequently asked questions about Atossa Therapeutics
Where is Atossa Therapeutics headquartered?
Atossa Therapeutics, Inc. is headquartered in Seattle, Washington, United States.
What does Atossa Therapeutics do?
Atossa Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Atossa Therapeutics a public company?
Yes. Atossa Therapeutics, Inc. trades on Nasdaq under the ticker ATOS.
When was Atossa Therapeutics founded?
The earliest incorporation on record for Atossa Therapeutics, Inc. is in 2009, according to public company registers.
Similar companies
- Omeros CorpSeattle, Washington, United States
- Chinook Therapeutics, Inc.Seattle, Washington, United States
- Cti Biopharma CorpSeattle, Washington, United States
- Perspective Therapeutics, Inc.Seattle, Washington, United States
- Aptevo Therapeutics Inc.Seattle, Washington, United States
- IPI Legacy Liquidation CoSeattle, Washington, United States
- Alpine Immune Sciences, Inc.Seattle, Washington, United States
- NephroDI Therapeutics, Inc.Seattle, Washington, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences